Print this page    •   Back to Web version of article

International News
Health Canada Approves Abbott Diagnostic Instrument, HIV-1 and Hepatitis C Tests

January 10, 2007

On Monday, Abbott Laboratories Inc. and Celera Group announced that Health Canada had approved the Abbott m2000, an automated molecular diagnostic instrument, and the Abbott RealTime HIV-1 and hepatitis C viral load tests. The tests were developed for use on the m2000 instrument, which is used to conduct genetic testing in molecular laboratories. Abbott said the m2000 can measure viruses and bacteria in blood or plasma samples in five hours or less.

Back to other news for January 10, 2007

Excerpted from:
Associated Press

This article was provided by CDC National Prevention Information Network. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update. You can find this article online by typing this address into your Web browser:

General Disclaimer: is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.